Pacific Biosciences Sequel II Systems Deployed to Scale-Up Global Viral Surveillance Initiatives Focused on COVID-19
18 févr. 2021 08h01 HE
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq: PACB), a leading provider of high-quality, long-read sequencing platforms, today announced that...
Pacific Biosciences of California, Inc. Announces Fourth Quarter and Fiscal Year 2020 Financial Results
10 févr. 2021 16h02 HE
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for the quarter and fiscal year ended December 31,...
Pacific Biosciences Announces $900 Million Investment from SoftBank to Support Growth Initiatives
10 févr. 2021 08h00 HE
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) (the “Company”), a leading provider of high-quality, long-read sequencing platforms,...
Pacific Biosciences Grants Equity Incentive Award to New Employee
05 févr. 2021 17h00 HE
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Feb. 05, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality sequencing...
Pacific Biosciences Grants Equity Incentive Award to New Employee
29 janv. 2021 16h15 HE
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Jan. 29, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality sequencing...
Pacific Biosciences of California, Inc. Fourth Quarter 2020 Financial Results Call
27 janv. 2021 14h30 HE
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Jan. 27, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its fourth quarter 2020 financial...
Pacific Biosciences and Invitae to Develop Ultra-High-Throughput Clinical Whole Genome Sequencing Platform
13 janv. 2021 08h02 HE
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Jan. 13, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq: PACB), a leading provider of high-quality, long-read sequencing platforms, today announced a...
Pacific Biosciences Grants Equity Incentive Awards to New Employees
12 janv. 2021 18h26 HE
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Jan. 12, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality, long read...
Pacific Biosciences of California, Inc. Announces Preliminary Fourth Quarter 2020 Revenue
11 janv. 2021 07h45 HE
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (the “Company”) (NASDAQ: PACB), a leading provider of high-quality sequencing platforms, today announced...
Pacific Biosciences Announces Appointments of Mark Van Oene as Chief Operating Officer and Peter Fromen as Chief Commercial Officer
08 janv. 2021 08h45 HE
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Jan. 08, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB), a leading provider of high-quality sequencing solutions, today announced the...